Lorad continues record sales pace

Article

Despite recessionary pressures, Lorad counts 1994 as another record year, with revenue growthin excess of 45%. The Danbury, CT, mammography equipment manufacturerreported sales of $55 million for the fiscal year ending Dec.31, compared to $37.5 million

Despite recessionary pressures, Lorad counts 1994 as another record year, with revenue growthin excess of 45%. The Danbury, CT, mammography equipment manufacturerreported sales of $55 million for the fiscal year ending Dec.31, compared to $37.5 million in 1993, according to chief executiveHal Kirschner.

The firm's financial contribution to parent company ThermoThrexalso increased substantially, Kirschner said.

Lorad reported growth in all segments, but Kirschner attributedparticular strength to sales of the StereoGuide prone breast biopsysystem and its DSM digital spot mammography option. Unit and dollarsales increased considerably last year, he said.

"We also had nice growth in domestic mammography sales,as well as 100% increase in sales overseas of products sold byboth Lorad and our OEM partner Philips," he said.

Lorad was a key contributor to a spectacular year for ThermoThrex.Revenue generated in 1994 by the diversified imaging and opticalinstrument group increased 67% to $91 million.

Income growth was off the chart. The San Diego-based subsidiaryof Thermo Electron reported profits of $9.6 million compared to$495,000 in the previous year.

Kirschner sees strong signs of continued growth for Lorad thisyear. Sales bookings in January and February reached all-timehighs.

"That indicator, coupled with our strong backlog, willhelp us continue the compounded 40% annual growth pattern we'vemaintained in the past four years," he said.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.